{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:37:22Z","timestamp":1780893442805,"version":"3.54.1"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030-146923"],"award-info":[{"award-number":["310030-146923"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030-165990"],"award-info":[{"award-number":["310030-165990"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Swiss Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Research Priority Program Integrative Human Physiology"},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lindenberg Family Office"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,14]]},"DOI":"10.1093\/cvr\/cvae145","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T01:52:11Z","timestamp":1722477131000},"page":"1369-1371","source":"Crossref","is-referenced-by-count":1,"title":["Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-3947","authenticated-orcid":false,"given":"Yu-Jen","family":"Wang","sequence":"first","affiliation":[{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zurich , Wagistrasse 12, 8952 Schlieren ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-1767","authenticated-orcid":false,"given":"Christian M","family":"Matter","sequence":"additional","affiliation":[{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zurich , Wagistrasse 12, 8952 Schlieren ,","place":["Switzerland"]},{"name":"Department of Cardiology, University Heart Center Zurich, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"2024101413514556300_cvae145-B1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2024101413514556300_cvae145-B2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2019.02.013","article-title":"HDAC inhibition as a therapeutic strategy in myocardial ischemia\/reperfusion injury","volume":"129","author":"Xie","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"2024101413514556300_cvae145-B3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2119\/molmed.2011.00021","article-title":"Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus","volume":"17","author":"Christensen","year":"2011","journal-title":"Mol Med"},{"key":"2024101413514556300_cvae145-B4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41569-019-0235-9","article-title":"Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2024101413514556300_cvae145-B5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024101413514556300_cvae145-B6","doi-asserted-by":"crossref","first-page":"105274","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged target in drug discovery: a perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol Res"},{"key":"2024101413514556300_cvae145-B7","doi-asserted-by":"crossref","first-page":"9494052","DOI":"10.1155\/2018\/9494052","article-title":"Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: potential role of peroxiredoxin 1 acetylation and redox regulation","volume":"2018","author":"Leng","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"2024101413514556300_cvae145-B8","doi-asserted-by":"crossref","first-page":"165728","DOI":"10.1016\/j.bbadis.2020.165728","article-title":"Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury","volume":"1866","author":"Herr","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2024101413514556300_cvae145-B9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cvr\/cvae144","article-title":"Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia\/reperfusion injury by limiting tumour necrosis factor alpha\u2013induced mitochondrial injury in experimental diabetes","volume":"120","author":"Baumgardt","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2024101413514556300_cvae145-B10","doi-asserted-by":"crossref","first-page":"e148333","DOI":"10.1172\/JCI148333","article-title":"HDAC6 modulates myofibril stiffness and diastolic function of the heart","volume":"132","author":"Lin","year":"2022","journal-title":"J Clin Invest"},{"key":"2024101413514556300_cvae145-B11","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"Granger","year":"2008","journal-title":"FASEB J"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae145\/58700107\/cvae145.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/12\/1369\/59747202\/cvae145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/12\/1369\/59747202\/cvae145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T02:56:00Z","timestamp":1732416960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/12\/1369\/7724672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":11,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,7,31]]},"published-print":{"date-parts":[[2024,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae145","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,31]]}}}